FI20011465A0 - Pyridatsinonijohdannaisen uusi käyttö - Google Patents
Pyridatsinonijohdannaisen uusi käyttöInfo
- Publication number
- FI20011465A0 FI20011465A0 FI20011465A FI20011465A FI20011465A0 FI 20011465 A0 FI20011465 A0 FI 20011465A0 FI 20011465 A FI20011465 A FI 20011465A FI 20011465 A FI20011465 A FI 20011465A FI 20011465 A0 FI20011465 A0 FI 20011465A0
- Authority
- FI
- Finland
- Prior art keywords
- new use
- pyridazinone derivative
- mammal
- pyridazinone
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20011465A FI20011465A0 (fi) | 2001-07-04 | 2001-07-04 | Pyridatsinonijohdannaisen uusi käyttö |
DE60217336T DE60217336T2 (de) | 2001-07-04 | 2002-07-04 | Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens |
ES02743320T ES2278930T3 (es) | 2001-07-04 | 2002-07-04 | Uso de un derivado de la piridazinona en el tratamiento de una insuficiencia cardiaca congestiva. |
PCT/FI2002/000605 WO2003004035A1 (en) | 2001-07-04 | 2002-07-04 | New use of a pyridazinone derivative |
EP02743320A EP1401450B1 (de) | 2001-07-04 | 2002-07-04 | Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens |
CA002450821A CA2450821A1 (en) | 2001-07-04 | 2002-07-04 | New use of a pyridazinone derivative |
AT02743320T ATE350101T1 (de) | 2001-07-04 | 2002-07-04 | Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens |
JP2003510046A JP2004535457A (ja) | 2001-07-04 | 2002-07-04 | ピリダジノン誘導体の新しい用途 |
US10/750,846 US20040180895A1 (en) | 2001-07-04 | 2004-01-05 | Use of a pyridazinone derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20011465A FI20011465A0 (fi) | 2001-07-04 | 2001-07-04 | Pyridatsinonijohdannaisen uusi käyttö |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20011465A0 true FI20011465A0 (fi) | 2001-07-04 |
Family
ID=8561590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20011465A FI20011465A0 (fi) | 2001-07-04 | 2001-07-04 | Pyridatsinonijohdannaisen uusi käyttö |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040180895A1 (de) |
EP (1) | EP1401450B1 (de) |
JP (1) | JP2004535457A (de) |
AT (1) | ATE350101T1 (de) |
CA (1) | CA2450821A1 (de) |
DE (1) | DE60217336T2 (de) |
ES (1) | ES2278930T3 (de) |
FI (1) | FI20011465A0 (de) |
WO (1) | WO2003004035A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
MX2017004842A (es) * | 2014-10-15 | 2017-06-22 | Orion Corp | Levosimendan para uso en el tratamiento de enfermedades de las neuronas motoras (por ejemplo esclerosis lateral amiotrofica). |
EP3993773A1 (de) | 2019-07-01 | 2022-05-11 | Orion Corporation | Verfahren zur verabreichung (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamid |
US11969424B2 (en) | 2019-12-16 | 2024-04-30 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4397854A (en) * | 1981-05-14 | 1983-08-09 | Warner-Lambert Company | Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
US4517310A (en) * | 1981-07-28 | 1985-05-14 | Berlex Laboratories, Inc. | N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and use thereof as a cardiotonic agent |
US4432979A (en) * | 1981-10-26 | 1984-02-21 | William H. Rorer, Inc. | Pyridone compounds |
JP3131845B2 (ja) * | 1991-06-12 | 2001-02-05 | 帝国臓器製薬株式会社 | 慢性心不全治療剤 |
FI973804A (fi) * | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
FI980901A (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
US5905078A (en) * | 1998-06-19 | 1999-05-18 | Orion Corporation | Use of a pyridazinone derivative |
FI20011464A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon |
-
2001
- 2001-07-04 FI FI20011465A patent/FI20011465A0/fi unknown
-
2002
- 2002-07-04 ES ES02743320T patent/ES2278930T3/es not_active Expired - Lifetime
- 2002-07-04 DE DE60217336T patent/DE60217336T2/de not_active Expired - Lifetime
- 2002-07-04 EP EP02743320A patent/EP1401450B1/de not_active Expired - Lifetime
- 2002-07-04 CA CA002450821A patent/CA2450821A1/en not_active Abandoned
- 2002-07-04 WO PCT/FI2002/000605 patent/WO2003004035A1/en active IP Right Grant
- 2002-07-04 AT AT02743320T patent/ATE350101T1/de not_active IP Right Cessation
- 2002-07-04 JP JP2003510046A patent/JP2004535457A/ja active Pending
-
2004
- 2004-01-05 US US10/750,846 patent/US20040180895A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60217336D1 (de) | 2007-02-15 |
US20040180895A1 (en) | 2004-09-16 |
CA2450821A1 (en) | 2003-01-16 |
WO2003004035A1 (en) | 2003-01-16 |
DE60217336T2 (de) | 2007-10-04 |
EP1401450B1 (de) | 2007-01-03 |
ES2278930T3 (es) | 2007-08-16 |
ATE350101T1 (de) | 2007-01-15 |
JP2004535457A (ja) | 2004-11-25 |
EP1401450A1 (de) | 2004-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062031L (no) | Derivater av N-[fenyl(alkylptpertdtn-2-yl)metyl]benzamid, fremgangsmate for fremstilling derav og anvendelse derav i terapeutiske media | |
DK1188747T3 (da) | Phenoxypropylaminforbindelser | |
EA200300621A1 (ru) | Биарильные производные никотинамида, полезные в качестве ингибиторов изоферментов pde4 | |
SE9703375D0 (sv) | A new combination | |
HUP0004725A2 (hu) | 2-[3,5-Bisz-(trifluor-metil)-fenil]-N-metil-N-(6-morfolin-4-il-4-o-tolil-piridin-3-il)-izobutiramid | |
HUP0101132A2 (hu) | Amidvegyületet tartalmazó, szinergetikus hatású fungicid hatóanyag keverék és alkalmazása | |
FI20011465A0 (fi) | Pyridatsinonijohdannaisen uusi käyttö | |
NO984481D0 (no) | 4-((thien-3-yl)metyl) imidazolderivater med <alfa>-2-adrenoceptor agonistisk aktivitet | |
DE60213087D1 (de) | Pyrimidin-derivate als selektive inhibitoren von cox-2 | |
DK0683777T3 (da) | Oxindol-1-N-(alkoxycarbonyl)carboxamider og -1-(N-carboxamido)carboxamider som antiinflammatoriske midler | |
IL140032A0 (en) | New use of a pyridazinone derivative | |
MA27812A1 (fr) | Utilisation d'un inhibiteur de tyrosine kinase c-abl, pdgf-r ou c-kit dans le traitement du diabete | |
BR0312242A (pt) | 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil]-benzamida para o tratamento da fibrose pulmonar | |
TR200202439T2 (tr) | Sodyum hidrojen değiştirici tip 1 önleyici (NHE-1) | |
CA2361390A1 (en) | Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain | |
BR0002578A (pt) | Novas arilpiperazinilalquil-3 (2h) - piridazinonas | |
PE20050674A1 (es) | Derivados de cromano | |
DE60216441D1 (de) | Mittel zur verbesserung der gewebepenetration | |
RS50861B (sr) | 1,3-dioksolani kao sredstva protiv kašlja | |
TR199903001T2 (xx) | 2-{4-$4-(4,5-Dikloro-2-metilimidazol-1-YL) Butil]-1-piperazinil}-5-floropirimidin, haz�rlan��� ve tedavi edici olarak kullan�m�. | |
CO4810303A1 (es) | Derivados de n-[3-[2-[(2,3-dihidro-1h-inden-2-il)alquilami- no]-etil]fenil]carboxamida, su preparacion y su aplicacion en terapeutica | |
PT1075476E (pt) | Novos benzimidazoles e benzoxazoles | |
RU2307831C3 (ru) | N3-алкилированные бензимидазольные производные в качестве ингибиторов mek | |
DE60305460D1 (de) | Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen | |
TH13037EX (th) | " สารประกอบใหม่ " |